PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of Russia (PRIORITY-CKD)
Multicenter, Non-interventional Observational Prospective Study With Retrospective Analysis to Describe the Rate of CKD Diagnosis, in Patients With Arterial Hypertension and CKD Markers
Sponsor: AstraZeneca
Listed as NCT06372431, this observational or N/A phase trial focuses on Arterial Hypertension, Chronic Kidney Disease and remains actively recruiting participants. Sponsored by AstraZeneca, it has been updated 10 times since 2024, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Jul 2025 — Sep 2025 [monthly]
Recruiting
-
May 2025 — Jul 2025 [monthly]
Recruiting
-
Apr 2025 — May 2025 [monthly]
Recruiting
-
Feb 2025 — Apr 2025 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Oct 2024 — Feb 2025 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
Jan 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AstraZeneca
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aramil, Russia , Chelyabinsk, Russia , Irkutsk, Russia , Kaluga, Russia , Kazan', Russia , Kemerovo, Russia , Krasnodar, Russia , Krasnoyarsk, Russia , Moscow, Russia , Nizhny Novgorod, Russia and 20 more locations